In fiscal year 2019, the research and development expenditure of Noevir Holdings Co., Ltd. amounted to approximately *** billion Japanese yen. Noevir Holdings is known for producing and selling various skincare items as well as pharmaceuticals and health food.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Noevir. (December 27, 2019). Research and development expenditure of Noevir Holdings Co., Ltd. from fiscal year 2015 to 2019 (in billion Japanese yen) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 31, 2026, from /statistics/1092923/noevir-research-development-expenditure/
Noevir. "Research and development expenditure of Noevir Holdings Co., Ltd. from fiscal year 2015 to 2019 (in billion Japanese yen)." Chart. December 27, 2019. ÌÇÐÄÆÆ½â°æ. Accessed July 31, 2026. /statistics/1092923/noevir-research-development-expenditure/
Noevir. (2019). Research and development expenditure of Noevir Holdings Co., Ltd. from fiscal year 2015 to 2019 (in billion Japanese yen). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 31, 2026. /statistics/1092923/noevir-research-development-expenditure/
Noevir. "Research and Development Expenditure of Noevir Holdings Co., Ltd. from Fiscal Year 2015 to 2019 (in Billion Japanese Yen)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 27 Dec 2019, /statistics/1092923/noevir-research-development-expenditure/
Noevir, Research and development expenditure of Noevir Holdings Co., Ltd. from fiscal year 2015 to 2019 (in billion Japanese yen) ÌÇÐÄÆÆ½â°æ, /statistics/1092923/noevir-research-development-expenditure/ (last visited July 31, 2026)
Research and development expenditure of Noevir Holdings Co., Ltd. from fiscal year 2015 to 2019 (in billion Japanese yen) [Graph], Noevir, December 27, 2019. [Online]. Available: /statistics/1092923/noevir-research-development-expenditure/